<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00922844</url>
  </required_header>
  <id_info>
    <org_study_id>NL24375.041.08</org_study_id>
    <nct_id>NCT00922844</nct_id>
  </id_info>
  <brief_title>The Effect of Sevoflurane Versus Isoflurane on Vasopressor Need</brief_title>
  <acronym>ESIVAN</acronym>
  <official_title>The Effect of Sevoflurane Versus Isoflurane on Vasopressor Need</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>UMC Utrecht</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this study is to determine the effect of isoflurane versus sevoflurane on blood
      pressure and systemic vascular resistance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In modern anesthesia a variety of volatile anesthetics is available. In cardiac
      anesthesiology both isoflurane and sevoflurane are frequently used. At present the number of
      studies comparing the influence of isoflurane and sevoflurane on blood pressure and systemic
      vascular resistance is limited. Moreover, the results presented in the available literature
      are inconsistent. The decision as to which of both volatiles should be used during cardiac
      surgery is not evidence-based, but is based on personal preference of the anesthesist. The
      most reliable way to compare the effects of isoflurane and sevoflurane on blood pressure and
      systemic vascular resistance is a randomized controlled trial in patients during
      Cardiopulmonary bypass (CPB).
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    too slow recruitment; lack of funding
  </why_stopped>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total amount of the vasopressor phenylephrine that is needed to maintain blood pressure above 60 mmHg during 10 minutes of Cardiopulmonary bypass.</measure>
    <time_frame>10 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean blood pressure throughout the 10 minute periods, the need for a stronger vasopressor (norepinephrine) and the inability to keep mean blood pressure below 75 mmHg at MAC 0.6.</measure>
    <time_frame>10 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Hypotension</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of the volatile anesthetic Sevoflurane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of the volatile anesthetic Isoflurane.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane and isoflurane</intervention_name>
    <description>Patients will be randomized to a 10 minute treatment with isoflurane, followed by a wash-out period, followed by a 10 minute treatment with sevoflurane, or the other way round.</description>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_label>Isoflurane</arm_group_label>
    <other_name>Sevorane/isoflurane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  competent adult patients (18 years or older)undergoing elective coronary artery bypass
             grafting with the use of the cardiopulmonary bypass.

        Exclusion Criteria:

          -  Patients undergoing valve surgery or combined surgical procedures (e.g. coronary
             artery bypass grafting in combination with valve reconstruction.

          -  uncontrolled hypertension

          -  a poor left ventricular function

          -  renal failure

          -  a body mass index of &gt; 25

          -  history of cerebrovascular accident, transient ischemic accident or carotid artery
             stenosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>C.J. Kalkman, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Center</name>
      <address>
        <city>Utrecht</city>
        <zip>3984 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2009</study_first_submitted>
  <study_first_submitted_qc>June 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2009</study_first_posted>
  <last_update_submitted>April 18, 2015</last_update_submitted>
  <last_update_submitted_qc>April 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UMC Utrecht</investigator_affiliation>
    <investigator_full_name>D van Dijk</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>hypotension</keyword>
  <keyword>low blood pressure</keyword>
  <keyword>vasopressor need</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Vasoconstrictor Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

